Health Care/Hospital
Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals
Discovery-based pharmaceutical company in Japan leverages Cloudera for greater speed to insights across its research, development, and post-market value chain. SINGAPORE, April 6, 2022 /PRNewswire/ -- Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company,Sh...
Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis
SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today t...
Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business
NEW YORK, April 6, 2022 /PRNewswire/ -- Mindtree
Digital Engagement Continues to Soar Amongst Biopharmas in APAC
SYDNEY, April 6, 2022 /PRNewswire/ -- Veeva Systems
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK
LONDON, April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd.
Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions
SINGAPORE, April 5, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients...
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNew...
TraceLink Launches its Opus Compliance Framework with the Release of the Brazil Compliance Solution on the Opus Platform
The Opus™ Compliance Framework Enables Rapid Development of Compliance Solutions To Keep Pace With Increasing Country Mandates BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company, announces the release of its Opus™ Compliance Framework with the relea...
Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols
JAKARTA, April 5, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming
G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series
that took place on28-30 March 2022 in Yogyakarta, Indonesia.
Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis
HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals
Deals mark an important step toward AMR Action Fund's goal of bringing two to four new antibiotics to market to take on growing threat of drug-resistant bacteria BOSTON, April 4, 2022 /PRNewswire/ -- The AMR Action Fund, the world's largest public-private partnership investing in biotech compani...
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province
HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets inZhejiang Province has been completed. On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"),...
International Virchow Prize for Global Health launched
Highly prestigious award endowed with €500,000 to uphold the United Nations
2030 Agenda
- Picture is available at AP Images (http://www.apimages.com
Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients
Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON, April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted inf...
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia
BANGKOK, April 4, 2022 /PRNewswire/ -- SeaX Ventures (Southeast Asia Exponential Ventures) announced today the close of its second fund to help accelerate the growth of global startups throughoutSoutheast Asia. The fund is dedicated to investing in companies working on truly transformational opp...
B.I.G. VISION® FOR ALL from Rodenstock: Optimal vision with biometric lenses for everyone
MUNICH, April 4, 2022 /PRNewswire/ -- Everyone's appearance is so different and individual and so too are their eyes. Rodenstock recognised that every eye is different and developed an innovative technology that determines the personal biometrics of the eye from several thousand measuring points ...
Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization
TEL AVIV, Israel, April 4, 2022 /PRNewswire/ -- Radiaction Medical Ltd.
Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project
MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded$23 million in Federal Government grant funding under t...
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China
TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...
Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022
SAN FRANCISCO and SUZHOU, China, April 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 276 media titles]
2024-04-15 08:00Animated Life in Yunnan
[Picked up by 276 media titles]
2024-04-18 14:00